Pulmonary vasculitis in Behçet’s disease: reference atlas computed tomography pulmonary angiography (CTPA) findings and risk assessment-management proposal
Main Article Content
Keywords
Behçet’s disease, pulmonary vasculitis; pulmonary artery pseudoaneurysms; True pulmonary artery aneurysms; vasculitis management.
Abstract
Background and aim. Pulmonary artery aneurysms (PAAs) are the most well-defined type of pulmonary vascular complication in Behçet's disease (BD).The aim of this study is to analyze which CT pulmonary angiography (CTPA) signs are associated with serious morbidity and mortality.
Methods. The study included 42 BD patients with pulmonary vascular complications. All patients' medical records were reviewed retrospectively in terms of demographics, disease characteristics, laboratory investigations, pulmonary manifestations, arterial and/or venous thrombosis and CTPA vascular and parenchymal findings.
Results. Deep venous thrombosis was observed in 31(73.8%) patients, arterial thrombosis in 13(31%), peripheral arterial aneurysms in 12(286%), haemoptysis in 38 (90.5%), and fatal haemoptysis in 8(19 %) patients. CTPA revealed: in situ thrombosis in 14(33.3%) patients, true stable PAAs in 13(31), true unstable PAAs in 11(26.2%), stable pulmonary artery pseudoaneurysms (PAPs) in 7(16.7%), unstable PAPs in 17(40.5%), the latter were associated with perianeurysmal leaking in 26(61.9%) and bronchial indentation in 19(45.2%).In regression analysis, fatal outcomes were associated with age in years (p=0.035), arterial thrombosis (p=0.025), peripheral arterial aneurysms (p=0.010), intracardiac thrombosis (p=0.026) and positively associated with haemoptysis severity (p<0.001).
Conclusion. Peripheral arterial thrombosis and/or aneurysms, intracardiac thrombosis and haemoptysis severity are predictor of fatal outcomes in BD pulmonary vasculitis. PAPs with perianeurysmal alveolar haemorrhage and/or bronchial indentation are serious CTPA signs that require prompt identification and aggressive treatment. PAPs are a more serious aneurysmal pattern than true PAAs because they are a contained rupture of a PA branch in the context of pulmonary vasculitis.
References
[2] Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2020: Behçet's syndrome. Clin Exp Rheumatol.2020; 127:3-10.
[3] Emad Y, Abdel-Razek N, Gheita T, el-Wakd M, el-Gohary T, Samadoni A. Multislice CT pulmonary findings in Behçet's disease (report of 16 cases). Clin Rheumatol 2007;26:879-84. doi: 10.1007/s10067-006-0408-x.
[4] Greene RM, Saleh A, Taylor AK, Callaghan M, Addis BJ, Nzewi OC, van Zyl WV, Non-invasive assessment of bleeding pulmonary artery aneurysms due to Behçet disease. EurRadiol.1998;8:359-63. doi: 10.1007/s003300050394.
[5] Cozzi D, Moroni C, Cavigli E, Bindi A, Bonini MC, Fattorini C, et al. Behçet disease in Emergency Department: a rare case presenting with haemoptysis and massive pulmonary arterial aneurysms. Sarcoidosis Vasc Diffuse Lung Dis.2021;38:e2021014. doi: 10.36141/svdld.v38i2.10957.
[6] Emad Y, Ragab Y, Kechida M, Guffroy A, Kindermann M, Robinson C, et al. A critical analysis of 57 cases of Hughes-Stovin syndrome (HSS). A report by the HSS International Study Group (HSSISG). Int J Cardiol.2021;331:221-229. doi: 10.1016/j.ijcard.2021.01.056.
[7] Emad Y, Ragab Y, Robinson C, Pankl S, Young P, Fabi M, et al. Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group. Clin Rheumatol. 2021;40:4993-5008. doi: 10.1007/s10067-021-05912-3.
[8] Emad Y, Ragab Y, ShawkiAel-H, Gheita T, El-Marakbi A, Salama MH. Hughes-Stovin syndrome: is it incomplete Behçet's? Report of two cases and review of the literature. Clin Rheumatol. 2007;26:1993-6. doi: 10.1007/s10067-007-0609-y.
[9]Bennji SM, du Preez L, Griffith-Richards S, Smit DP, Rigby J, Koegelenberg CFN, et al. Recurrent Pulmonary Aneurysms: Hughes-Stovin Syndrome on the Spectrum of Behçet Disease. Chest.2017; 152:e99-e103. doi: 10.1016/j.chest.2017.07.015.
[10] François MF. Is Hughes-Stovin syndrome a particular expression of Behçet's disease? Chest.1983;83:288. doi: 10.1378/chest.83.2.288a.
[11] Numan F, Islak C, Berkmen T, Tüzün H, CokyükselO.Behçet disease: pulmonary arterial involvement in 15 cases. Radiology. 1994;192:465-8. doi: 10.1148/radiology.192.2.8029416.
[12] Agha A, Bella AM, Assiri AH, Al-Hakami M. Can Behcet's Disease Related Pulmonary Arterial Aneurysms be Completely Resolved? Open Rheumatol J. 2011;5:88-90. doi: 10.2174/1874312901105010088.
[13] Tunaci M, Ozkorkmaz B, Tunaci A, Gül A, Engin G, Acunaş B. CT findings of pulmonary artery aneurysms during treatment for Behçet's disease. AJR Am J Roentgenol1999;172:729-33. doi: 10.2214/ajr.172.3.10063870.
[14] Hassine E, Bousnina S, Marniche K, Fennira H, Ben Khelil J, Ben Mustapha MA, et al. Anévrysmes des artèrespulmonaires au cours de la maladie de Behçet [Pulmonary artery aneurysms in Behçet's disease: contribution of imaging in 5 cases]. Ann Med Interne (Paris).2002;153:147-52.
[15] Mahendran C, Singh P, Mani NB, Jindal SK. Successful treatment of pulmonary artery aneurysms secondary to possible Behçet's disease. Respiration. 2002; 69:355-8. doi: 10.1159/000063262.
[16] Takahama M, Yamamoto R, Nakajima R, Tada H. Successful surgical treatment of pulmonary artery aneurysm in Behçet’s syndrome. Interact Cardiovasc ThoracSurg. 2009;8:390-2. Doi: 10.1510/icvts.2008.194647.
[17] Xie D, Chen C, Wang H, Xu Z, Jiang G.Refractory pulmonary artery aneurysm in Behçet’s disease. Ann Transl Med. 2015; 3:239. doi: 10.3978/j.issn.2305-5839.2015.09.27.
[18] Kage H, Goto Y, Amano Y, Makita K, Isago H, Kobayashi K, et al. Development of Pulmonary Artery Aneurysms Due to Behçet's Disease and Resolution after Treatment. Intern Med. 2016;55:3337-3340. doi: 10.2169/internalmedicine.55.6852.
[19] Ouchi K, Narui R, Sakuma T, Ojiri H. Serious Complication of Anticoagulation in Vessel Thrombosis-associated Behçet Disease. Intern Med.2020;59:1615-1620. doi: 10.2169/internalmedicine.4109-19.
[20] Tharwat S, ElAdle SS, Moshrif AH, Ismail F, El-Shereef R, Talaat EA, et al. Egyptian College of Rheumatology (ECR) Behçet’s disease study groups. Computed tomography pulmonary angiography (CTPA) in Behçet's disease patients: a remarkable gender gap and time to refine the treatment strategy. Clin Rheumatol. 2022;41:195-201. doi: 10.1007/s10067-021-05991-2.
[21] Santana AN, Antunes T, Barros JM, Kairalla RA, Carvalho CR, Barbas CS Acometimentopulmonarnadoença de Behçet: uma boa experiência com o uso de imunossupressores [Pulmonary involvement in Behcet's disease: a positive single-center experience with the use of immunosuppressive therapy]. J Bras Pneumol. 2008;34:362-6. Portuguese. doi: 10.1590/s1806-37132008000600005.
[22] Aroussi AA, Redai M, El Ouardi F, Mehadji BE. Bilateral pulmonary artery aneurysm in Behçet syndrome: report of two operative cases. J Thorac Cardiovasc Surg. 2005;129:1170-1. doi: 10.1016/j.jtcvs.2004.08.038.
[23] Cengiz Seyhan E, Zeki Gunluoglu M, Erol C. Pulmonary Artery Aneurysm Ruptured Into Bronchus in a Patient With Behçet's Disease. Arch Bronconeumol. 2017; 53:29. English, Spanish. doi: 10.1016/j.arbres.2015.12.011
24. [25] International Team for the Revision of the International Criteria for Behçet’s D, Davatchi F, Assaad-Khalil S, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M, et al. The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J EurAcad Dermatol Venereol. 2014; 28:338-47.doi: 10.1111/jdv.12107.
25. [24] Emad Y, Ragab Y, Ibrahim O, Saad A, Rasker JJ. Pattern of pulmonary vasculitis and major vascular involvement in Hughes-Stovin syndrome (HSS): brief report of eight cases. Clin Rheumatol. 2020; 39:1223-1228. doi: 10.1007/s10067-019-04872-z.
26.Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020 Jan;79(1):19-30. doi: 10.1136/annrheumdis-2019-215672.
[27] Gül A, Yilmazbayhan D, Büyükbabani N, Lie JT, Tunaci M, Tunaci A. Organizing pneumonia associated with pulmonary artery aneurysms in Behçet's disease. Rheumatology (Oxford).1999; 38:1285-9. doi: 10.1093/rheumatology/38.12.1285
[28] Barberis M, Casadio C, Borghini U. Massive haemoptysis in Behçet syndrome: case report. Respiration. 1987;52:303-7. doi: 10.1159/000195339.
[29] Chen Y, Gilman MD, Humphrey KL, Salazar GM, Sharma A, Muniappan A, et al. Pulmonary Artery Pseudoaneurysms: Clinical Features and CT Findings. AJR Am J Roentgenol. 2017;208:84-91. doi: 10.2214/AJR.16.16312
[30] Park HS, Chamarthy MR, Lamus D, Saboo SS, Sutphin PD, Kalva SP. Pulmonary artery aneurysms: diagnosis & endovascular therapy. Cardiovasc DiagnTher. 2018; 8:350-361. doi: 10.21037/cdt.2018.04.01.
[31] Aktoğu S, Erer OF, Urpek G, Soy O, Tibet G. Multiple pulmonary arterial aneurysms in Behçet's disease: clinical and radiologic remission after cyclophosphamide and corticosteroid therapy. Respiration. 2002; 69:178-81. doi: 10.1159/000056324.
[32] Yadav T, Saxena S, Dutt N, Garg P, Khera P. Vanishing aneurysms in Behcet's disease - A case series. Monaldi Arch Chest Dis.2021;91(1). doi: 10.4081/monaldi.2021.145
[33] Tolosa-Vilella C, Capela CA, Monteagudo-Jiménez M, Marí-Alfonso B. Infliximab for life-threatening pulmonary artery aneurysms in Behçet's disease. A case report. Clin Exp Rheumatol. 2011;29(4 Suppl 67):S94-5.
[34] Baki K, Villiger PM, Jenni D, Meyer T, Beer JH. Behcet's disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatment. Ann Rheum Dis. 2006; 65:1531-2. doi: 10.1136/ard.2005.045195.
[35]Schreiber BE, Noor N, Juli CF, HaskardDO.Resolution of Behçet's syndrome associated pulmonary arterial aneurysms with infliximab. Semin Arthritis Rheum. 2011; 41:482-7. doi: 10.1016/j.semarthrit.2011.02.006.
[36] Chan E, Sangle SR, Coghlan JG, D'Cruz DD.Pulmonary artery aneurysms in Behçet's disease treated with anti-TNFα: A case series and review of the literature. Autoimmun Rev. 2016; 15:375-8. doi: 10.1016/j.autrev.2016.01.003.
[37] Aamar S, Peleg H, Leibowitz D, Chajek-Shaul T, Hiller N, Heyman SN. Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Behçet's disease. Rheumatol Int. 2014;34:857-60. doi: 10.1007/s00296-013-2693-4.
[38] Kotecha J, Kamath AV, Mukhtyar C. Behçet's pulmonary artery aneurysms treated with infliximab and monitored with the 6-min walk test. Oxf Med Case Reports. 2016;Apr 26;2016(4):94-6. doi: 10.1093/omcr/omw028.
[39] Kirk GM, Seal RM. False aneurysm of the pulmonary artery with peripheral venous thrombosis. Thorax. 1964;19:449–453. https:// doi. org/ 10. 1136/ thx. 19.5. 449
[40] Pelage JP, El Hajjam M, Lagrange C, Chinet T, Vieillard-Baron A, Chagnon S, et al. Pulmonary artery interventions: an overview. Radiographics. 2005; 25:1653-67. doi: 10.1148/rg.256055516
[41] Al Bshabshe A, Assiri A, Somaily M. Massive hemoptysis secondary to Behçet's aneurysm controlled with endobronchial balloon lung isolation: Case report and review of literature. Respir Med Case Rep. 2020 May 28;30:101105. doi: 10.1016/j.rmcr.2020.101105.
[42] Park A, Cwikiel W. Endovascular treatment of a pulmonary artery pseudoaneurysm with a stent graft: report of two cases. Acta Radiol. 2007;48(1):45-7. doi: 10.1080/02841850601045104
[43] Matsumoto T, Uekusa T, Fukuda Y. Vasculo-Behçet's disease: a pathologic study of eight cases. Hum Pathol.1991;22:45-51. doi: 10.1016/0046-8177(91)90060-3.
[44] van der Houwen TB, van Hagen PM, van Laar JAM. Immunopathogenesis of Behçet's disease and treatment modalities. Semin Arthritis Rheum. 2022; 52:151956. doi: 10.1016/j.semarthrit.2022.151956.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Yasser Ragab, Radiology Department, Faculty of Medicine, Cairo University, Kasr Al-Ainy St, 11562 Cairo, Egypt.
Radiology Department, Faculty of Medicine, Cairo University, Kasr Al-Ainy St., Cairo, 11562, Egypt.
Diletta Cozzi, Department of Emergency Radiology, Careggi University Hospital, Florence, Italy.
Department of Emergency Radiology, Careggi University Hospital, Florence, Italy.
Ossama Ibrahim, 4 Morecambe Bay University Hospitals Lancaster, Ashton Rd.,Lancashire Lancaster LA1 4RP, UK
Morecambe Bay University Hospitals Lancaster, Ashton Rd.,Lancashire Lancaster LA1 4RP, UK
Walaa Abdelrahman, Department of Rheumatology and Rehabilitation, Department of Radiology, Faculty of Medicine, Cairo University, Cairo, Egypt
Rheumatology Department, Faculty of Medicine, Cairo University, Kasr Al-Ainy St., Cairo, 11562, Egypt.
How to Cite
